Our experience highlights the diagnostic challenges posed by presacral tumors’ embryological complexity (Table 4), exemplified by the malignant teratoma case where immunohistochemical markers (CDX2+/CK20+) failed to resolve the pathological dichotomy between malignant teratoma transformation (23), and tailgut origin theories (24). The gene discussed is CDX2; the disease is malignant teratoma.